Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (Q60637647)
Jump to navigation
Jump to search
scholarly article published in Nature Medicine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial |
scholarly article published in Nature Medicine |
Statements
Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (English)
0 references
October 2007
0 references
13
0 references
10
0 references
1264-1264
0 references